Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Changes

12 Mar 2021 09:00

RNS Number : 9998R
Sainsbury(J) PLC
12 March 2021
 

12 March 2021

J Sainsbury plc - Directorate Changes

Appointment of Adrian Hennah as Non-Executive Director and Chair of Audit Committee

J Sainsbury plc today announces that Adrian Hennah will join the Board as a Non-Executive Director. Adrian will join the Audit Committee and Nomination Committee on 1 April 2021 and will take over as Chair of the Audit Committee following the AGM.

Adrian will replace David Keens, who is not seeking re-election to the Board at the July 2021 AGM after six years of service.

Commenting on the appointment, Martin Scicluna, Chairman of Sainsbury's, said:

"I am delighted to welcome Adrian as a Non-Executive Director and Chair of the Audit Committee. As a highly accomplished CFO of three FTSE100 companies spanning 18 years, he has significant and varied expertise. Additionally, Adrian was a Non-Executive Director and Audit Committee Chair of another FTSE100 company for nine years and I am confident he will bring fresh thinking to our Board as we deliver against our plan.

"I would like to thank David Keens for his six years of service. He has been a thoughtful and influential voice on the Board and we are grateful for his significant contribution."

Adrian Hennah said:

"I am very pleased to be joining Sainsbury's and look forward to bringing my experience to the Board. I am familiar with the business through previous roles and have always been impressed by the company's values and commitment to do the right thing for its customers. It is an exciting time to be involved in food retail and I am looking forward to getting started."

Adrian spent 18 years in Chief Financial Officer (CFO) roles at three FTSE 100 companies. He was CFO at RB for seven years and held the same position at Smith & Nephew and Invensys. Prior to this he spent 18 years at GSK working in both finance and operations. Adrian began his career at PWC.

Adrian was previously Non-Executive Director and Chair of the Audit Committee at RELX. He stepped down from the Board last year having completed nine years of service. No further information is required to be disclosed under 9.6.13R of the UK Listing Rules.

 

Ends

Enquiries:

Investor Relations Media Relations

James Collins +44 (0) 20 7695 0080 Rebecca Reilly +44 (0) 20 7695 7295

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFFFXLEBBF
Date   Source Headline
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSCommencement of Share Buyback Programme
6th Nov 20257:00 amRNSHalf-Year Report
3rd Nov 20252:15 pmRNSTotal Voting Rights
24th Oct 20253:55 pmRNSDirector/PDMR Shareholding
7th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20259:10 amRNSChange of Registrar
3rd Oct 20254:50 pmRNSHolding(s) in Company
1st Oct 20252:15 pmRNSTotal Voting Rights
26th Sep 20253:00 pmRNSDirector/PDMR Shareholding
15th Sep 20257:00 amRNSTermination of discussions with JD.com
12th Sep 20252:00 pmRNSCompletion of Share Buyback Programme
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20251:45 pmRNSTotal Voting Rights
29th Aug 20253:15 pmRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20252:30 pmRNSBlock listing Interim Review
1st Aug 20252:15 pmRNSTotal Voting Rights
1st Aug 20252:00 pmRNSDirector/PDMR Shareholding
31st Jul 202510:00 amRNSHolding(s) in Company
29th Jul 202511:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20253:30 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 202511:08 amRNSDirector/PDMR Shareholding
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20252:40 pmRNSDirector/PDMR Shareholding
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20254:10 pmRNSResult of AGM
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 202512:55 pmRNSEMTN Programme Supplementary Prospectus
1st Jul 202510:45 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.